GAM
NKTR icon

Gemmer Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Gemmer Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24
Closed -$5K – 1287
2021
Q4 		$5K Sell
24
-9
-27% -$1.95K ﹤0.01% 1004
2021
Q3 		$9K Hold
33
– – ﹤0.01% 747
2021
Q2 		$9K Buy
33
+13
+65% +$3.6K ﹤0.01% 839
2021
Q1 		$6K Buy
20
+2
+11% +$622 ﹤0.01% 989
2020
Q4 		$5K Buy
18
+1
+6% +$258 ﹤0.01% 988
2020
Q3 		$4K Buy
17
+1
+6% +$315 ﹤0.01% 980
2020
Q2 		$6K Sell
16
-7
-30% -$2.18K ﹤0.01% 794
2020
Q1 		$6K Sell
23
-80
-78% -$24.7K ﹤0.01% 701
2019
Q4 		$33K Sell
103
-4
-4% -$1.16K 0.01% 267
2019
Q3 		$29K Buy
107
+14
+15% +$5.13K 0.01% 290
2019
Q2 		$49K Buy
93
+77
+481% +$38.6K 0.01% 190
2019
Q1 		$8K Hold
16
– – ﹤0.01% 800
2018
Q4 		$8K Sell
16
-6
-27% -$3.62K ﹤0.01% 716
2018
Q3 		$20K Sell
22
-11
-33% -$9.39K 0.01% 405
2018
Q2 		$24K Sell
33
-1
-3% -$1.15K 0.01% 340
2018
Q1 		$53K Buy
34
+1
+3% +$1.29K 0.02% 175
2017
Q4 		$29K Buy
33
+2
+6% +$1.18K 0.01% 304
2017
Q3 		$11K Hold
31
– – ﹤0.01% 627
2017
Q2 		$9K Hold
31
– – ﹤0.01% 699
2017
Q1 		$11K Hold
31
– – ﹤0.01% 608
2016
Q4 		$6K Hold
31
– – ﹤0.01% 846
2016
Q3 		$8K Hold
31
– – ﹤0.01% 704
2016
Q2 		$7K Buy
31
+4
+15% +$894 ﹤0.01% 731
2016
Q1 		$5K Sell
27
-58
-68% -$11.1K ﹤0.01% 832
2015
Q4 		$21K Buy
85
+71
+507% +$14.6K 0.01% 292
2015
Q3 		$2K Buy
+14
New +$2.48K ﹤0.01% 1106

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Gemmer Asset Management's NKTR Position: Q1 2022 in Review

Gemmer Asset Management sold out of Nektar Therapeutics (NKTR) in Q1 2022, closing a stake of 24 shares — an estimated $5K sold.

Gemmer Asset Management first reported a position in NKTR in Q3 2015 and held it in 26 quarters. The position peaked at $53K in Q1 2018. 239 funds tracked by Wall St. Rank hold NKTR as of Q1 2022.

  • Gemmer Asset Management reported no remaining Nektar Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 24 Nektar Therapeutics shares in Q1 2022, an estimated $5K.
  • Gemmer Asset Management first reported a position in Nektar Therapeutics in Q3 2015 and held it in 26 quarters.
  • Gemmer Asset Management's Nektar Therapeutics position peaked at $53K in Q1 2018.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2022.

Based on Gemmer Asset Management's 13F filing for Q1 2022, filed 20 Apr 2022.